These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 223567)

  • 1. Effect of polyanetholesulphonic acid and xylan sulphate on antithrombin III activity.
    Kindness G; Williamson FB; Long WF
    Biochem Biophys Res Commun; 1979 Jun; 88(3):1062-8. PubMed ID: 223567
    [No Abstract]   [Full Text] [Related]  

  • 2. The molecular mechanisms of heparin action III. The anticoagulant properties of polyanetholesulfonate.
    Walker FJ; Esmon CT
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1339-46. PubMed ID: 212063
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.
    Simmons RB; Newton GR; Doctor VM
    Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of bactericidal properties of human blood by polyanetolsulphonate sodium and sodium dextran-sulphate (author's transl)].
    Potuzník V
    Cesk Epidemiol Mikrobiol Imunol; 1979 Apr; 28(3):151-4. PubMed ID: 226277
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of dithiothreitol on the modulation of antithrombin III activity by sulphated polysaccharides.
    Long WF; Williamson FB
    Biochem Soc Trans; 1981 Feb; 9(1):68-9. PubMed ID: 7215671
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence for antithrombin III involvement in the anticoagulant activity of cellulose sulphate.
    Kindness G; Long WF; Williamson FB
    Br J Pharmacol; 1980 Apr; 68(4):645-9. PubMed ID: 7378640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of the inhibitory effect of sodium polyanetholesulfonate on Neisseria meningitidis in blood cultures processed with the Du Pont Isolator System.
    Scribner RK; Welch DF
    J Clin Microbiol; 1984 Jul; 20(1):40-2. PubMed ID: 6086709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a heparan sulphate with high affinity for antithrombin III upon inactivation of thrombin and coagulation factor Xa.
    Scully MF; Ellis V; Shah N; Kakkar V
    Biochem J; 1989 Sep; 262(2):651-8. PubMed ID: 2529852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquoid and platelet aggregation.
    Iatridis SG; Iatridis PG; Kyrkou KA; Markidou SG; Wonnell DM
    Thromb Res; 1980 Feb 1-15; 17(3-4):415-23. PubMed ID: 6245478
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
    Kudriashov BA; Liapina LA; Pastorova VE
    Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant effects of sulphated polysaccharides in normal and antithrombin III-deficient plasmas.
    Kindness G; Long WF; Williamson FB
    Br J Pharmacol; 1980 Aug; 69(4):675-7. PubMed ID: 6159941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of sodium polyanethol sulfonate (SPS) on the growth of bacteria in blood cultures].
    Baykal M
    Mikrobiyol Bul; 1979 Jan; 13(1):63-71. PubMed ID: 233490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The consumption of antithrombin III during coagulation, its consequences for the calculation of prothrombinase activity and the standardisation of heparin activity.
    Béguin S; Kessels H; Dol F; Hemker HC
    Thromb Haemost; 1992 Aug; 68(2):136-42. PubMed ID: 1412157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Xylan Sulfates on Coagulation of Human Blood Plasma.
    Drozd NN; Kuznetsova SA; Levdansky VA; Mikhailenko MA
    Bull Exp Biol Med; 2017 Dec; 164(2):158-161. PubMed ID: 29185171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of monoclonal antibodies against the human thrombin-antithrombin III complex.
    Asakura S; Yoshida N; Matsuda M; Murayama H; Soe G
    Biochim Biophys Acta; 1988 Jan; 952(1):37-47. PubMed ID: 3422029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstration of altered antithrombin III activity due to nonenzymatic glycosylation at glucose concentration expected to be encountered in severely diabetic patients.
    Villanueva GB; Allen N
    Diabetes; 1988 Aug; 37(8):1103-7. PubMed ID: 3391345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the kinetic behavior of human and bovine proteins in the heparin-catalyzed antithrombin III/thrombin reaction.
    Cunningham MT; Nelsestuen GL
    Biochim Biophys Acta; 1987 Jan; 911(1):66-70. PubMed ID: 3790599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permeability of a heparin-polyvinyl alcohol hydrogel to thrombin and antithrombin III.
    Smith BA; Sefton MV
    J Biomed Mater Res; 1988 Aug; 22(8):673-85. PubMed ID: 3215905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.